000 | 01649 a2200493 4500 | ||
---|---|---|---|
005 | 20250514011503.0 | ||
264 | 0 | _c20020522 | |
008 | 200205s 0 0 eng d | ||
022 | _a0253-5068 | ||
024 | 7 |
_a10.1159/000046967 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVarela, M P | |
245 | 0 | 0 |
_aBiocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels. _h[electronic resource] |
260 |
_bBlood purification _c2001 |
||
300 |
_a370-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBiocompatible Materials _xchemistry |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aCellulose _xanalogs & derivatives |
650 | 0 | 4 |
_aComplement C3a _xdrug effects |
650 | 0 | 4 |
_aComplement C5a _xdrug effects |
650 | 0 | 4 |
_aComplement System Proteins _xdrug effects |
650 | 0 | 4 |
_aCytokines _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunity, Cellular _xdrug effects |
650 | 0 | 4 |
_aInterleukin-1 _xblood |
650 | 0 | 4 |
_aInterleukin-2 _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMembranes, Artificial |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRenal Dialysis _xadverse effects |
650 | 0 | 4 | _aTemperature |
700 | 1 | _aKimmel, P L | |
700 | 1 | _aPhillips, T M | |
700 | 1 | _aMishkin, G J | |
700 | 1 | _aLew, S Q | |
700 | 1 | _aBosch, J P | |
773 | 0 |
_tBlood purification _gvol. 19 _gno. 4 _gp. 370-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000046967 _zAvailable from publisher's website |
999 |
_c11496449 _d11496449 |